180 related articles for article (PubMed ID: 31727225)
1. Psychopharmacology of neurobehavioral disorders.
Mooney LN; Dominick KC; Erickson CA
Handb Clin Neurol; 2019; 165():383-390. PubMed ID: 31727225
[TBL] [Abstract][Full Text] [Related]
2. ASD, ADHD, mental health conditions and psychopharmacology in neurogenetic syndromes: parent survey.
Reilly C; Senior J; Murtagh L
J Intellect Disabil Res; 2015 Apr; 59(4):307-18. PubMed ID: 24965264
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and behavioral heterogeneity in genetic syndromes.
Pegoraro LF; Steiner CE; Celeri EH; Banzato CE; Dalgalarrondo P
J Pediatr (Rio J); 2014; 90(2):155-60. PubMed ID: 24184301
[TBL] [Abstract][Full Text] [Related]
4. Psychopathological disorders in Prader-Willi syndrome.
Guinovart M; Coronas R; Caixàs A
Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):579-587. PubMed ID: 31006652
[TBL] [Abstract][Full Text] [Related]
5. Implications of genomic imprinting for psychiatric genetics.
Flint J
Psychol Med; 1992 Feb; 22(1):5-10. PubMed ID: 1533465
[No Abstract] [Full Text] [Related]
6. Elimination disorders in persons with Prader-Willi and Fragile-X syndromes.
Equit M; Piro-Hussong A; Niemczyk J; Curfs L; von Gontard A
Neurourol Urodyn; 2013 Sep; 32(7):986-92. PubMed ID: 23239431
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.
de Vries BB; Fryns JP; Butler MG; Canziani F; Wesby-van Swaay E; van Hemel JO; Oostra BA; Halley DJ; Niermeijer MF
J Med Genet; 1993 Sep; 30(9):761-6. PubMed ID: 8411072
[TBL] [Abstract][Full Text] [Related]
8. Short form of the developmental behaviour checklist.
Taffe JR; Gray KM; Einfeld SL; Dekker MC; Koot HM; Emerson E; Koskentausta T; Tonge BJ
Am J Ment Retard; 2007 Jan; 112(1):31-9. PubMed ID: 17181389
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology, medical management and dental implications of fragile X, Rett, and Prader-Willi syndromes.
Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
J Calif Dent Assoc; 2003 Sep; 31(9):693-702. PubMed ID: 14560873
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
Banga A; Connor DF
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):396-8. PubMed ID: 23083028
[No Abstract] [Full Text] [Related]
11. Pharmacotherapy for mental health problems in people with intellectual disability.
Ji NY; Findling RL
Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
[TBL] [Abstract][Full Text] [Related]
12. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome.
Stein DJ; Keating J; Zar HJ; Hollander E
J Neuropsychiatry Clin Neurosci; 1994; 6(1):23-9. PubMed ID: 8148633
[TBL] [Abstract][Full Text] [Related]
13. Family contexts, parental behaviour, and personality profiles of children and adolescents with Prader-Willi, fragile-X, or Williams syndrome.
van Lieshout CF; De Meyer RE; Curfs LM; Fryns JP
J Child Psychol Psychiatry; 1998 Jul; 39(5):699-710. PubMed ID: 9690933
[TBL] [Abstract][Full Text] [Related]
14. Investigating Autism-Related Symptoms in Children with Prader-Willi Syndrome: A Case Study.
Bennett JA; Hodgetts S; Mackenzie ML; Haqq AM; Zwaigenbaum L
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264487
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review: Emotion Dysregulation in Syndromic Causes of Intellectual and Developmental Disabilities.
Shaffer RC; Reisinger DL; Schmitt LM; Lamy M; Dominick KC; Smith EG; Coffman MC; Esbensen AJ
J Am Acad Child Adolesc Psychiatry; 2023 May; 62(5):518-557. PubMed ID: 36007813
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome.
Ezell J; Hogan A; Fairchild A; Hills K; Klusek J; Abbeduto L; Roberts J
J Autism Dev Disord; 2019 Mar; 49(3):1131-1141. PubMed ID: 30430320
[TBL] [Abstract][Full Text] [Related]
17. A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders.
Valdovinos MG; Epperson C; Johnson C
Int Rev Neurobiol; 2023; 173():43-65. PubMed ID: 37993179
[TBL] [Abstract][Full Text] [Related]
18. Behavioural phenotypes and family stress in three mental retardation syndromes.
Sarimski K
Eur Child Adolesc Psychiatry; 1997 Mar; 6(1):26-31. PubMed ID: 9112044
[TBL] [Abstract][Full Text] [Related]
19. Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls.
Kim JW; Yoo HJ; Cho SC; Hong KE; Kim BN
J Child Neurol; 2005 Feb; 20(2):134-8. PubMed ID: 15794180
[TBL] [Abstract][Full Text] [Related]
20. [Social cognition in children with neurogenetic syndromes: A literature review].
Morel A; Demily C
Arch Pediatr; 2017 Aug; 24(8):757-765. PubMed ID: 28668215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
